Enhanced production of glomerular extracellular matrix in a new mouse strain of high serum IgA ddY mice

Kidney International

Volumn 50, Issue 6, 1996, Pages 1946-1957

  Muso, Eri ^a   Yoshida, Haruyoshi ^b   Takeuchi, Eiji ^b   Yashiro, Masatomo ^b   Matsushima, Hiroyuki ^b   Oyama, Atsushi ^b   Suyama, Katsuo ^b   Kawamura, Takahide ^b   Kamata, Tadashi ^b   Miyawaki, Shigeki ^b   Izui, Shozo ^b   Sasayama, Shigetake ^b  

^a KYOTO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; EXTRACELLULAR MATRIX; GLOMERULUS; IMMUNOGLOBULIN A NEPHROPATHY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL;

EID: 10544231048     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.517     Document Type: Article

References (44)

1. BERGER J, HINGLAIS N: Intercapillary deposits of IgA-IgG. J Urol Nephrol Paris 74:694-695, 1968
2. BERGER J: IgA glomerular deposits in renal disease. Transplant Proc 1:939-944, 1969
3. JULIAN BA, WALDO FB, RIFAI A, MESTECKY J: IgA nephropathy, the most common glumerulonephritis worldwide. A neglected disease in the United States? Am J Med 84:129-132, 1988
4. CHAUVEAU D, DROZ D: Follow-up evaluation of the first patients with IgA nephropathy described at Necker Hospital. Contrib Nephrol 104:1-5, 1993
5. MCCOY RC, ABRAMOWSKY CR, TISHER CC: IgA nephropathy. Am J Pathol 76:123-144, 1974
6. D'AMICO G: Clinical features and natural history in adults with IgA nephropathy. Am J Kidney Dis 12:353-357, 1988
7. WOODROFFE AJ, CORMLY AA, MCKENZIE PE, WOOTTON AM, THOMPSON AJ, SEYMOUR AE, CLARKSON AR: Immunologic studies in IgA nephropathy. Kidney Int 18:366-374, 1980
8. BERGER J: Idiopathic mesangial deposition of IgA (chapt 32), Nephrology, edited by HAMBURGER J, CROSNIER J, GRÜNFELD J-P, New York, Wiley-Flammarion, 1979, pp 535-541
9. LAYWARD L, ALLEN AC, HATTERSLEY JM, HARPER SJ, FEEHALLY J: Elevation of IgA in IgA nephropathy is localized in the serum and not saliva and is restricted to the IgA 1 subclass. Nephrol Dial Transplant 8:25-28, 1993
10. CAGNOLI L, BELTRANDI E, PASQUALI S, BIAGI R, CASADEI-MALDINI M, ROSSI L, ZUCCHELLI P: B and T cell abnormalities in patients with primary IgA nephropathy. Kidney Int 28:646-651, 1985
11. LAMM ME, EMANCIPATOR SN, GALLO GR: Relevance of an experimental model to clinical IgA nephropathy. Contrib Nephrol 40:32-36, 1984
12. RIFAI A, SMALL P JR, AYOUB EM: Experimental IgA nephropathy. Factors governing the persistence of IgA-antigen complexes in the circulation of mice. Contrib Nephrol 40:37-44, 1984
13. IMAI H, NAKAMOTO Y, ASAKURA K, MIKI K, YASUDA T, MIURA AB: Spontaneous glomerular IgA deposition in ddY mice: An animal model of IgA nephritis. Kidney Int 27:756-761, 1985
14. TAKEUCHI E, DOI T, SHIMADA T, MUSO E, MARUYAMA N, YOSHIDA H: Retroviral gp70 antigen in spontaneous mesangial glomerulonephritis of ddY mice. Kidney Int 35:638-646, 1989
15. MUSO E, YOSHIDA H, TAKEUCHI E, SHIMADA T, YASHIRO M, SUGIYAMA T, KAWAI C: Pathogenic role of polyclonal and polymeric IgA in a murine model of mesangial proliferative glomerulonephritis with IgA deposition. Clin Exp Immunol 84:459-465, 1991
16. MONTEIRO RC, HALBWACHS-MECARELLI L, ROQUE-BARREIRA MC, NOEL LH, BERGER J, LESAVRE P: Change and size of mesangial IgA in IgA nephropathy. Kidney Int 28:666-671, 1985
17. BORDER WA, OKUDA S, LANGUINO LR, RUOSLAHTI E: Transforming growth factor-β regulates production of proteoglycans by mesangial cells. Kidney Int 37:689-695, 1990
18. NAKAMURA T, MILLER D, RUOSLAHTI E, BORDER WA: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β1. Kidney Int 41:1213-1221, 1992
19. OKUDA S, LANGUINO LR, RUOSLAHTI E, BORDER WA: Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86:453-462, 1990 [erratum, J Clin Invest 86:2175, 1990].
20. TAMAKI K, OKUDA S, ANDO T, IWAMOTO T, NAKAYAMA M, FUJISHIMA M: TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 45:525-536, 1994
21. DERYNIK R, JARRETT JA, CHEN EY, EATON DH, BELL JK, ASSOIAN RK, ROBERTS AB, SPORN MB, GOEDDEL DV: Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316:701-705, 1985
22. TAN CEL, CHAN VSW, YONG, RYY, VIJAYAN V, TAN WL, CHONG SMCF, HO JMS, CHENG HH: Distortion in TGFβ1 peptide immunolocalization in biliary atresia: Comparison with the normal pattern in the developing hyman intrahepatic bile duct system. Pathol Int 45:815-824, 1995
23. KREISBERG JI, HOOVER PL, KARNOVSKY MJ: Isolation and characterization of rat glomerular epithelial cells in vitro. Kidney Int 14:21-30, 1978
24. WOODROFFE A, WILLSON CB: An evaluation of elution techniques in the study of immune complex glomerulonephritis. J Immunol 118: 1788-1794, 1977
25. MERINO R, SHIBATA T, DE-KOSSODO S. IZUI S: Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice. Eur J Immunol 19:2131-2137, 1989
26. KENNEL SJ: Purification of a glycoprotein from mouse ascites fluid by immunoaffinity chromatography which is related to the major glycoprotein of murine leukemia viruses: Immunologic and structural comparison with purified viral glycoproteins. J Biol Chem 251:6197-6204, 1976
27. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
28. OBERBAUMER I, LAURENT M, SCHWARZ U, SAKURAI Y, YAMADA Y, VOGELI G, VOSS T, SIEBOLD B, GLANVILLE RW, KUHN K: Amino acid sequence of the non-collagenous globular domain (NCl) of the alpha 1 (IV) chain of basement membrane collagen as derived from complementary DNA. Eur J Biochem 147:217-224, 1985
29. TSO JY, SUN XH, KAO TH, REECE KS, WU R: Isolation and characterization of rat and human glyceraldenyde-3-phospnate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucl Acid Res 13:2485-2502, 1985
30. DUAN HJ, NAGATA T: Glomerular extracellular matrices and anionic sites in aging ddY mice: A morphometric study. Histochemistry 99:241-249, 1993
31. YOSHIOKA K, TOHDA M, TAKEMURA T, AKANON, MATSUARA K, OOSHIMA A, MAKI S: Distribution of type I collagen in human kidney diseases in comparison with type III collagen. J Pathol 162:141-148, 1990
32. BORDER WA, OKUDA S, LANGUINO LR, SPORN MB, RUOSLAHTI E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346:371-374, 1990
33. YAMAMOTO T, NAKAMUKA T, NOBLE NA, RUOSLAHTI E, BORDER WA: Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
34. BORDER WA, RUOSLAHTI E: Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 90:1-7, 1992
35. LAI KN: Increased mRNA encoding for transforming growth factor-β in CD4+ cells from patients with IgA nephropathy. Kidney Int 46:862-868, 1994
36. YOSHIOKA K, TAKEMURA T, MURAKAMI K, OKADA M, HINO S, MIYAMOTO H, MAKI S: Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 68:154-163, 1993
37. MACKAY K, STRIKER LJ, STAUFFER JW, DOI T, AGODOA LY, STRIKER GE: Transforming growth factor-β. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 83:1160-1167, 1989
38. HABERSTROH U, ZAHNER G, DISSER M, THAISS F, WOLF G, STAHL RA: TGF-β stimulates rat mesangial cell proliferation in culture: Role of PDGF β-receptor expression. Am J Pathol 33:F199-F205, 1993
39. COFFMAN RL, LEBMAN DA, SHRADER B: Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med 170:1039-1044, 1989
40. SONODA E, MATSUMOTO R, HITOSHI Y, ISHII T, SUGIMOTO M, ARAKI S, TOMINAGA A, YAMAGUCHI N, TAKATSU K: Transforming growth factor β induces IgA production and acts additively with interleukin 5 for IgA production. J Exp Med 170:1415-1420, 1989
41. SHIMIZU M, TOMINO Y, ABE M, SHIRAI T, KOIDE H: Retroviral envelope glycoprotein (gp70) is not a prerequisite for pathogenesis of primary immunoglobulin A nephropathy in ddY mice. Nephron 62:328-331, 1992
42. YOSHIKI T, MELLORS RC, STRAND M, AUGUST JT: The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med 140:1011-1027, 1974
43. NAKAI Y, MARUYAMA N, OHTA K, YOSHIDA H, HIROSE S, SHIRAI T: Genetic studies of autoimmunity in New Zealand mice. Association of circulating retroviral gp70 immune complex with proteinuria. Immunol Lett 2:53-58, 1980
44. MARUYAMA N, FURUKAWA F, NAKAI Y, SASAKI Y, OHTA K, OZAKI S, HIROSE S, SHIRAI T: Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB X NZW) F1 hybrid and the correlation to renal disease. J Immunol 130:740-746, 1983